PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 194 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,781,593 | +161.7% | 119,331 | +195.9% | 0.17% | +32.8% |
| Q4 2019 | $1,827,000 | +20.0% | 40,325 | +0.8% | 0.13% | +14.9% |
| Q3 2019 | $1,523,000 | -61.3% | 40,000 | -55.8% | 0.11% | -58.2% |
| Q2 2019 | $3,932,000 | +241.9% | 90,418 | +151.9% | 0.27% | +362.7% |
| Q2 2018 | $1,150,000 | -93.6% | 35,895 | -92.5% | 0.06% | -93.5% |
| Q3 2017 | $17,965,000 | – | 478,400 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |